glp-1 shortage canada news today News: Latest Updates on Weight Loss and Diabetes Medications GLP-1 Drug Coverage in Canada

PlexusDx works with prescribing providers to document clinical rationale for alternative compounds or, if appropriate, to explore whether a future window of improved gastric health might permit GLP-1 initiation

(eClinicalMedicine, 2024) - found that 52 weeks of once-weekly semaglutide at 1.0 mg reduced hip bone mineral density by 2.6% and lumbar spine BMD by 2.1% compared to placebo in 64 adults with elevated fracture risk

It is also suggested that zinc deficiency may be an important risk factor of diabetes mellitus II

In such cases, the guideline instructs you to assign the appropriate code for the drug use, abuse, or dependence instead. So, per this guideline, we can assume that you should report long-term drug use other than in cases of addiction, or for conditions such as detoxification or drug withdrawal, with a Z79 code